Biontech: Get Latest News, Photos and Videos along with latest updates on Biontech | Hindustan Times



Latest from biontech

Pharmaceutical firms Pfizer, BioNTech sue Poland and Hungary over Covid debts

EU member countries ordered vaccines for their population through joint purchase scheme, and so companies are bringing their case before the courts in Belgium.

Pfizer confirmed the cases were under way but would not confirm the sums demanded. (Reuters)
Published on Dec 19, 2023 07:52 PM IST

Moderna sues Pfizer, BioNTech for Covid vaccine patent infringement

Moderna accused Pfizer and BioNTech of violating intellectual property protecting key elements of Moderna’s messenger RNA technology in developing the Comirnaty vaccine.

Early in the Covid crisis, Moderna promised not to enforce its intellectual property during the pandemic, but on March 7 it modified that pledge to apply only to lower-income countries.(AFP)
Updated on Aug 26, 2022 07:18 PM IST
Bloomberg |

Qatar approves Pfizer/BioNTech vaccine for children aged 5-11 years

In November, Gulf states Bahrain and Saudi Arabia approved the Pfizer Covid-19 vaccine for emergency use for children in the same age category.

A dose of a Pfizer Covid-19 vaccine is prepared at children's hospital.(AP)
Published on Jan 30, 2022 09:21 PM IST
Reuters |

Omicron routs J&J vaccine in lab study, may evade Sinovac and BioNTech too

A study, conducted by scientists at the microbiology department of the University of Hong Kong, showed that insufficient antibodies were generated by the Sinovac and BioNTech products to fend off Omicron.

Omicron is more infectious than Delta, but it remains unclear whether it is also more dangerous. (File Photo)
Published on Dec 15, 2021 01:26 PM IST
Written by Joydeep Bose | Edited by Avik Roy, Hindustan Times, New Delhi

Pfizer, BioNTech say 3 doses of Covid-19 vaccine neutralise Omicron variant

Further, the companies also said that two doses of the vaccine was found less effective in protection against the Omicron variant while a booster dose increased the neutralising antibodies by 25 times.

Pfizer-BioNTech said that an Omicron-specific Covid-19 vaccine, if needed, could be delivered by March 2022, pending regulatory approvals.(AP)
Published on Dec 08, 2021 07:47 PM IST
Written by Srivatsan K C | Edited by Avik Roy, Hindustan Times, New Delhi
Story Saved
Live Score
Saved Articles
My Reads
Sign out
New Delhi 0C
Saturday, June 15, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On